Corbus Pharma (CRBP) Tops Q3 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/30/2026
- S&P 500 dips, Nasdaq higher after data shows moderate inflation rise
- Equity positioning stays overweight, but summer extremes have eased: Barclays
- Oil prices rise by about $1/bbl on stalled US-Iran talks and tight fuel markets
- Micron reports Q4 today: Why Lynx Equity sees massive upside
- Moderna: Citi says oncology optimism is priced in, cuts rating to sell
- Salesforce agrees to acquire AI research platform Listen Labs
- Workday cuts 2.5% of workforce, revises GAAP margin outlook
- Zimbabwe helicopter crash kills six, government spokesperson says
- Apple's iOS 27 is blocking Trade Desk ads on Safari, analyst says
- S&P 500 dips, Nasdaq higher after data shows moderate inflation rise
Form S-3 Corbus Pharmaceuticals
November 10, 2015 5:21 PM ESTTable of Contents
As filed with the Securities and Exchange Commission on November 10, 2015
Registration No. 333-
... More
Form 10-Q Corbus Pharmaceuticals For: Sep 30
November 10, 2015 5:07 PM EST
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC... More
